Contributor Page
Ropes & Gray LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
New York
NY 10036-8704
United States
By Michael B. Lampert
In the 2012 election, we heard that the Affordable Care Act would be repealed.
By Dalila Argaez Wendlandt, Henry Huang
On March 21, 2017, in SCA Hygiene Products v. First Quality Baby Products, LLC, the Supreme Court overturned long-standing Federal Circuit law regarding the defense of laches, holding that laches is not a defense to damages for patent infringement.
By Douglas Hallward-Driemeier, Matthew Rizzolo, Samuel Brenner
What impact could the pending Supreme Court argument and decision in TC Heartland v. Kraft have on patent infringement litigation in the United States?
By Ropes & Gray LLP's Health Care Practice
The only certain effect that the Trump Administration will have on health care in America is that the Congress will pass, and the President will sign into law, a bill that has the word "repeal" prominently featured.
By Ropes & Gray LLP's Health Care Practice
Drug and device makers, and related trade groups, have responded with proposals to provide additional clarity around value-based health care.
By Ropes & Gray LLP's ERISA Practice
On March 10, 2017, the U.S. Department of Labor (the "DOL") issued Field Assistance Bulletin No. 2017-01, announcing a temporary non-enforcement policy for non-compliance with its fiduciary rule.
By Ropes & Gray LLP's Securities & Futures Enforcement Practice
At the SEC Speaks 2017 conference, held in Washington, D.C. from February 24-25, 2017, senior SEC officials shared their observations about the SEC's Division of Enforcement's activity over the past year . . .
By Ropes & Gray LLP's Executive Compensation & Employee Benefits Practice, Ropes & Gray LLP's Health Care Practice
On Monday, March 6, 2017, the two House committees with primary jurisdiction over matters at the core of the Affordable Care Act (ACA) each released a committee print that the committees say will, combined, become the House Republicans' American Health Care Act (collectively, the AHCA), designed to repeal and replace the ACA
By Kellie Coombs
Kellie Combs, Ropes & Gray life sciences partner, analyzes three documents released by the FDA outlining the agency's current thinking regarding drug and device manufacturers' communication of information not contained in FDA-approved labeling.
By John Donovan, Robert Skinner, Amy Roy
On February 28, 2017, Judge Renée Bumb of the New Jersey federal district court entered judgment in favor of Hartford Funds Management Group, Inc. following last November's four-day bench trial...
By Monica Gogna, Michelle Moran
The FCA issued two important press releases on 3 March 2017, outlining its findings from its recent supervisory work on firms' use of dealing commission and firms ensuring effective oversight of best execution
By Deborah Monson, Lindsey K. Jones
The CFTC requested comments on many issues. Comments are due by March 20, 2017.
By Ropes & Gray LLP's ERISA Practice
On March 1, 2017, the U.S. Department of Labor (the "DOL") published a proposed rule that would delay the applicability date of its fiduciary rule from April 10, 2017 to June 9, 2017 (a 60-day delay).
By Ropes & Gray LLP's Privacy And Data Security Practice Group
The European Commission recently published a proposed Regulation on Privacy and Electronic Communications (the "Regulation"). The Regulation aims to update and broaden the scope of current rules under the ePrivacy Directive (2002/58/EC) on confidentiality of electronic communications ...
By Ropes & Gray LLP's Health Care Practice
February 27, 2017, President Trump gave his first address to a joint session of Congress, outlining key points of his administration's agenda
Contributor's Topics